In 2021, the global Infectious Disease Molecular Diagnostics Market was estimated to be worth approximately US$ 34 billion. With a projected CAGR of 4.2% over the next ten years, the market is expected to be worth nearly US$ 53 billion by the end of 2032. Rather than the traditional methods that required pathogen cu.
TOKYO and XIAMEN, China, March 27, 2023 Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd., and Precision Medicine Asia Co., Ltd. today announced that the Japanese Ministry of Health, Labour. | March 27, 2023
Molecular Diagnostics Market study by Data Bridge Market Research provides details about the market dynamics affecting this market, Market scope, Market